1. Home
  2. MBOT vs NTIP Comparison

MBOT vs NTIP Comparison

Compare MBOT & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$2.11

Market Cap

134.3M

Sector

Health Care

ML Signal

HOLD

Logo Network-1 Technologies Inc.

NTIP

Network-1 Technologies Inc.

N/A

Current Price

$1.31

Market Cap

32.0M

Sector

Miscellaneous

ML Signal

N/A

Company Overview

Basic Information
Metric
MBOT
NTIP
Founded
2010
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Multi-Sector Companies
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
134.3M
32.0M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
MBOT
NTIP
Price
$2.11
$1.31
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.75
N/A
AVG Volume (30 Days)
1.8M
17.6K
Earning Date
11-12-2025
11-06-2025
Dividend Yield
N/A
7.63%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$150,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3,119.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$1.16
52 Week High
$4.67
$1.90

Technical Indicators

Market Signals
Indicator
MBOT
NTIP
Relative Strength Index (RSI) 45.87 38.44
Support Level $1.95 $1.32
Resistance Level $2.14 $1.42
Average True Range (ATR) 0.13 0.05
MACD -0.01 -0.00
Stochastic Oscillator 26.67 3.63

Price Performance

Historical Comparison
MBOT
NTIP

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: